Article Details

Biosimilars Market to grow by USD 54.35 billion (2024-2028), cost advantage over biologics ...

Retrieved on: 2024-11-15 22:18:43

Tags for this article:

Click the tags to see associated articles and topics

Biosimilars Market to grow by USD 54.35 billion (2024-2028), cost advantage over biologics .... View article details on hiswai:

Excerpt

1.1 Monoclonal antibodies- Biosimilar monoclonal antibodies (mAbs) are large, complex proteins used by the immune system to identify and ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up